Pharmafocus wants to hear from you!

pharmafile | July 17, 2017 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, biotech, drugs, healthcare, pharma, pharmaceutical 

We are always looking for new ways to improve the next issue of Pharmafocus, and now we’re planning a new feature that focuses on you, the reader. Many of you work on the front lines of pharma and life sciences, affected by the issues that we report on every day.

Your insight is invaluable, and we want to hear your experiences and viewpoints on the latest developments and trends as they emerge.

Disagree with the latest drug approval decision? Maybe you, your family, or a patient are affected? Excited about the prospect of a promising set of new research findings? Or even want to discuss a topic as a feature in our regular ‘Opinion’ column? Whether it’s a throwaway observation or extended commentary, we want to hear what you have to say.

Get in touch with us at or direct message us on Twitter and share your comments and thoughts – the best could even make it into the upcoming issue.

Related Content

FDA approves IMIDEX’s AI-powered device VisiRad XR

The technological pharmaceutical company IMIDEX has been granted clearance from the US Food and Drug …

Artiva Biotherapeutics announces FDA clearance of IND for AlloNK and Rituximab combo

On 16 August 2023, the US Food and Drug Administration (FDA) officially cleared Artiva Biotherapeutics’ …

Zumutor’s cancer drug trial cleared by FDA

On 11 August 2023, the biopharmaceutical company Zumutor Biologics announced that the trial of its …

Latest content